1887

Abstract

Hepatitis B virus (HBV) preS1 fused to the GAL4 DNA-binding domain functioned as a transcriptional activation domain in yeast and mammalian cells. The GAL4-preS1 fusion proteins derived from the preSI of all three tested HBV subtypes (, and ) specifically activated the transcription of a or chloramphenicol acetyltransferase reporter gene linked to a GAL4-responsive promoter in transient transfection assays using yeast or HepG2 cells, respectively. Deletion analyses showed that the segments of preSI from residues 21 to 90 and from residues 21 to 56 are sufficient and essential for the activity, respectively. Stable expression of GAL4-preS1 in Chinese hamster ovary cells also produced transactivator activity. These results suggest that preS1 fused to any DNA- binding domain of transcription factors would have transactivation potential.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-5-1083
1997-05-01
2024-05-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/5/9152426.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-5-1083&mimeType=html&fmt=ahah

References

  1. Balsano C., Avantaggiati M. L., Natoli G., De Marzio E., Will H., Perricaudet M., Levrero M. 1991; Full-length and truncated versions of the hepatitis B virus X protein transactivate the c-myc protooncogene at the transcriptional level. Biochemical and Biophysical Research Communications 176:985–992
    [Google Scholar]
  2. Beasley R. 1988; Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer Research 61:1942–1956
    [Google Scholar]
  3. Dejean A., Bougueleret L., Grzeschik K. H., Tiollais P. 1986; Hepatitis B virus DNA integration in a sequence homologous to v-erb A and steroid receptor genes in a hepatocellular carcinoma. Nature 322:70–72
    [Google Scholar]
  4. de The H., Marchio A., Tiollais P., Dejean A. 1987; A novel steroid thyroid hormone receptor-related gene is appropriately expressed in human hepatocellular carcinoma. Nature 330:667–670
    [Google Scholar]
  5. Fields S., Jang S. K. 1991; Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046–1049
    [Google Scholar]
  6. Ganem D., Varmus H. E. 1987; The molecular biology of hepatitis B viruses. Annual Review of Biochemistry 56:651–693
    [Google Scholar]
  7. Gietz D., St Jean A., Woods R. A., Schiestl R. H. 1992; Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Research 20:1425
    [Google Scholar]
  8. Gorman C. M., Moffat L. F., Howard B. H. 1982; Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology 2:1044–1051
    [Google Scholar]
  9. Kekulé A. S., Lauer U., Meyer M., Caselman W. H., Hofschneider P. H., Koshy R. 1990; The preS/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343:457–461
    [Google Scholar]
  10. Kim Y. S., Kang H. S. 1984; Cloning and expression of hepatitis B virus surface antigen gene. Korean Biochemical Journal 17:70–79
    [Google Scholar]
  11. Lauer U., Weib L., Lipp M., Hofschneider P. H., Kekule A. S. 1994; The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation. Hepatology 19:23–31
    [Google Scholar]
  12. Lee C. Q., Yun Y., Hoeffler J. P., Habener J. F. 1990; Cyclic-AMP-responsive transcription activation of CREB-327 involves in-terdependent phosphorylated subdomains. EMBO Journal 9:4455–4465
    [Google Scholar]
  13. Meyer M., Caselmann W., Schluter V., Schreck R., Hofschneider P., Baeuerle P. 1992; Hepatitis B virus transactivator MHBst: activation of NF-kB, selective inhibition by antioxidants and integral transmembrane localization. EMBO Journal 11:2991–3001
    [Google Scholar]
  14. Miller J. H. 1972 Experiments in Molecular Genetics Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  15. Moriarty A. M., Hoyer B. H., Shih J. W., Gerin J. L., Hamer D. H. 1981; Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. Proceedings of the National Academy of Sciences, USA 78:2606–2610
    [Google Scholar]
  16. Nakamura T., Tokino T., Nagaya T., Matsubara K. 1988; Microdeletion associated with integration process of hepatitis B virus DNA. Nucleic Acids Research 16:4865–4873
    [Google Scholar]
  17. Neurath A. R., Kent S. B. H., Strick N., Parker K. 1986; Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429–436
    [Google Scholar]
  18. Neurath A. R., Seto B., Strick N. 1989; Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 7:234–236
    [Google Scholar]
  19. Okuda K. 1992; Hepatocellular carcinoma : recent progress. Hepatology 15:948–963
    [Google Scholar]
  20. Park S. S., Jin B. R., Han M. H., Hong H. J. 1994; Expression of soluble and functional single-chain antibody in Escherichia coli. Molecules and Cells 4:413–417
    [Google Scholar]
  21. Ptashne M. 1988; How eukaryotic transcriptional activators work. Nature 335:683–688
    [Google Scholar]
  22. Ramesh R., Panda S. K., Jameel S., Rajasambandam P. 1994; Mapping of the hepatitis B virus genome in hepatocellular carcinoma using PCR and demonstration of a potential trans-activator encoded by the frequently detected fragment. Journal of General Virology 75:327–334
    [Google Scholar]
  23. Sadowski I., Ma J., Triezenberg S., Ptashne M. 1988; GAL4-VP16 is an unusually potent transcriptional activator. Nature 335:563–564
    [Google Scholar]
  24. Sherker A., Marion P. 1991; Hepadnaviruses and hepatocellular carcinoma. Annual Review of Microbiology 45:475–508
    [Google Scholar]
  25. Wang J., Cheniverse X., Henglein B., Brechot C. 1990; Hepatitis B virus integration in a cyclin gene in a hepatocellular carcinoma. Nature 343:555–557
    [Google Scholar]
  26. Williamson M. P. 1994; The structure and function of proline-rich regions in proteins. Biochemical Journal 297:249–260
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-5-1083
Loading
/content/journal/jgv/10.1099/0022-1317-78-5-1083
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error